Ultragenyx Pharmaceutical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,661	1,646	3,101	3,082	2,696	4,233
Market Cap Growth	-47.30%	-46.93%	0.60%	14.35%	-36.32%	-36.89%
Enterprise Value	1,972	1,960	3,188	3,419	2,613	3,827
Last Close Price	17.12	16.73	33.22	37.62	38.37	61.13
PS Ratio	3.32	3.29	6.93	9.04	8.94	16.31
PB Ratio	138.38	137.08	14.80	14.26	9.21	6.21
P/TBV Ratio	-	-	119.17	60.65	21.95	7.67
EV/Sales Ratio	3.99	3.92	7.12	10.03	8.67	14.75
Debt / Equity Ratio	53.41	53.41	3.47	3.39	2.57	0.43
Net Debt / Equity Ratio	25.73	25.73	0.63	0.57	0.03	-0.66
Net Debt / EBITDA Ratio	-0.83	-0.83	-0.33	-0.29	-0.02	1.64
Net Debt / FCF Ratio	-	-	-0.39	-0.30	-0.02	1.47
Asset Turnover	-	-	0.37	0.29	0.24	0.21
Inventory Turnover	-	-	19.62	22.84	34.15	35.05
Quick Ratio	-	-	2.13	2.32	3.04	4.33
Current Ratio	-	-	2.37	2.61	3.38	4.72
Return on Equity (ROE)	-412.99%	-412.99%	-211.71%	-193.22%	-110.96%	-43.72%
Return on Assets (ROA)	-	-	-22.37%	-23.43%	-26.44%	-14.54%
Return on Capital Employed (ROCE)	-	-	-46.20%	-47.00%	-50.50%	-28.50%
Earnings Yield	-25.72%	-25.96%	-14.66%	-15.45%	-21.78%	-7.92%
FCF Yield	-	-	-10.86%	-13.22%	-15.29%	-7.18%
Buyback Yield / Dilution	-8.90%	-8.90%	-23.11%	-5.19%	-3.13%	-11.42%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.